On Monday, November 16, 2020, the Company, Sorrento Therapeutics, Inc., SRNE stock construct a change of 1.86 percent (Gain) in a total of its share price and having its trading value $6.57, which belongs to Healthcare sector and Biotechnology industry. The company?s Market capitalization was $1.63B with the total Outstanding Shares of 251.21M.
P/S, P/E, P/B & P/C values of (NASDAQ: SRNE):
Sorrento Therapeutics, Inc. institutional ownership is standing at 25.8 percent, while insider ownership is 15.71 percent. As of now, SRNE has a P/S, P/E and, P/B values of 39.37, 0, and 8.01 respectively. Its P/Cash is valued at 0.
The stock SMA50 is now at -23.53 percent. In looking, the SMA 200 we see that the stock has seen a 9.78 percent. The Company?s net profit margin for the 12 months at 0 percent. Comparatively, the gazes have a Gross margin of 78.8 percent.
Profitability ratios:
Looking into the profitability ratios of SRNE stock, an investor will find its ROE, ROA, ROI standing at -221.9 percent, -52 percent and, -91.3 percent, respectively.
Beta Factor:
A beta factor is used to measure the volatility of the stock. The stock remaining at 11.24 percent volatile for the week and 7.46 percent for the month.
Gross / Operating Margins of SRNE:
It calculates how much out of every dollar of sales a company actually keeps in earnings. Gross Margin is seen at 78.8 percent & Operating Margin seen at 0 percent.
Target Price:
Target Price informs the investors, aÿstockÿsurvey at which a trader is willing to buy or sell aÿstock.ÿAt which a trader projects that a buyer will buy a product. The company Sorrento Therapeutics, Inc. recorded it at $0.
Historical Performance In The News:
Taking a look at the performance of Sorrento Therapeutics, Inc. stock, an investor will come to know that the weekly performance for this stock is valuing at 14.06 percent, resulting in a performance for the month at -29.35 percent.
Therefore, the stated figure displays a quarterly performance of -46.5 percent, bringing six-month performance to 21.22 percent and year to date performance of 94.38 percent. As of now, Sorrento Therapeutics, Inc. has a P/S, P/E and, P/B values of 39.37, 0, and 8.01 respectively. Its P/Cash is valued at 0.
Earnings per Share Details of Sorrento Therapeutics, Inc.:
The EPS of SRNE is strolling at -1.46, measuring its EPS growth this year at -14.8 percent. As a result, the company has an EPS growth of -30.54 percent for the approaching year.
